Erratum to: Prostanoid EP1 receptors mediate up-regulation of the orphan nuclear receptor Nurr1 by cAMP-independent activation of protein kinase A, CREB and NF-κB: EP1 receptor up-regulation of Nurr1 (British Journal of Pharmacology, (2012), 166, 3, (1033-1046), 10.1111/j.1476-5381.2011.01817.x);Prostanoid EP1 receptors mediate up-regulation of the orphan nuclear receptor Nurr1 by cAMP-independent activation of protein kinase A, CREB and NF-κB

British Journal of Pharmacology

Volumn 166, Issue 3, 2012, Pages 1033-1046

  Ji, R ^a   Sanchez, C M ^a   Chou, C L ^a   Chen, X B ^a   Woodward, D F ^b   Regan, J W ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b ALLERGAN INC   (United States)

Author keywords

CREB; G protein coupled receptors; NF B; NR4A2; Nurr1; orphan nuclear receptors; PKA

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NUCLEAR RECEPTOR RELATED FACTOR 1; PROSTAGLANDIN E RECEPTOR 1; PROSTAGLANDIN E2; RECOMBINANT PROTEIN; RHO FACTOR;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REPORTER GENE; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; UPREGULATION;

EID: 84860848770     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.13858     Document Type: Erratum

References (44)

1. 1 receptor contributes to excitotoxicity and focal ischemic brain damage. Toxicol Sci 89: 265-270.
2. th Edition. Br J Pharmacol 164 (Suppl. 1): S1-S324.
3. 2 neurotoxicity. J Neurosci Res 85: 3109-3117.
4. 2 synthesis and signalling downstream of COX-2 represent potential targets for the prevention/treatment of colorectal cancer. Biochim Biophys Acta 1766: 104-119.
5. Cheng Z, Völkers M, Din S, Avitabile D, Khan M, Gude N, et al,. (2011). Mitochondrial translocation of Nur77 mediates cardiomyocyte apoptosis. Eur Heart J 32: 2179-2188.
6. Coleman RA, Smith WL, Narumiya S, (1994). VIII. International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev 46: 205-229.
7. Fujino H, Regan JW, (2006). EP4 prostanoid receptor coupling to a pertussis toxin-sensitive inhibitory G-protein. Mol Pharmacol 69: 13-18.
8. Fujino H, West KA, Regan JW, (2002). Phosphorylation of glycogen synthase kinase-3 and stimulation of T-cell factor signaling following activation of EP2 and EP4 prostanoid receptors by prostaglandin E2. J Biol Chem 277: 2614-2619.
9. Fulton AM, Ma X, Kundu N, (2006). Targeting prostaglandin E EP receptors to inhibit metastasis. Cancer Res 66: 9794-9797.
10. Gambaryan S, Kobsar A, Rukoyatkina N, Herterich S, Geiger J, Smolenski A, et al,. (2010). Thrombin and collagen induce a feedback inhibitory signaling pathway in platelets involving dissociation of the catalytic subunit of protein kinase A from an NFκB-IκB complex. J Biol Chem 285: 18352-18363.
11. Han C, Michalopoulos GK, Wu T, (2006). Prostaglandin E2 receptor EP1 transactivates EGFR/MET receptor tyrosine kinases and enhances invasiveness in human hepatocellular carcinoma cells. J Cell Physiol 207: 261-270.
12. Hayden MS, Ghosh S, (2008). Shared principles in NF-κB signaling. Cell 132: 344-362.
13. Holla VR, Mann JR, Shi Q, DuBois RN, (2006). Prostaglandin E2 regulates the nuclear receptor NR4A2 in colorectal cancer. J Biol Chem 281: 2676-2682.
14. Huang GW, Yang LY, Lu WQ, (2005). Expression of hypoxia-inducible factor 1α and vascular endothelial growth factor in hepatocellular carcinoma: impact on neovacularization and survival. World J Gastroenterol 11: 1705-1708.
15. i/o upregulates the expression of hypoxia-inducible factor-1α through activation of a phosphoinositide-3 kinase signaling pathway. Mol Pharmacol 77: 1025-1036.
16. Juneja J, Casey PJ, (2009). Role of G12 proteins in oncogenesis and metastasis. Br J Pharmacol 158: 32-40.
17. Kadkhodaei B, Ito T, Joodmardi E, Mattsson B, Rouillard C, Carta M, et al,. (2009). Nurr1 is required for maintenance of maturing and adult midbrain dopamine neurons. J Neurosci 29: 15923-15932.
18. Kawano T, Anrather J, Zhou P, Park L, Wang G, Frys KA, et al,. (2006). Prostaglandin E2 EP1 receptors: downstream effectors of COX-2 neurotoxicity. Nat Med 12: 225-229.
19. Ke N, Claassen G, Yu DH, Albers A, Fan W, Tan P, et al,. (2004). Nuclear hormone receptor NR4A2 is involved in cell transformation and apoptosis. Cancer Res 64: 8208-8212.
20. Kotani M, Tanaka I, Ogawa Y, Usui T, Tamura N, Mori K, et al,. (1997). Structural organization of the human prostaglandin EP3 receptor subtype gene (PTGER3). Genomics 40: 425-434.
21. Kurose H, (2003). Galpha12 and Galpha13 as key regulatory mediator in signal transduction. Life Sci 74: 155-161.
22. 2 receptors induces orphan nuclear receptor Nurr1 expression and stimulates cell proliferation in human lung cancer cells. Carcinogenesis 30: 1606-1613.
23. Li H, Kolluri SK, Gu J, Dawson MI, Cao X, Hobbs PD, et al,. (2000). Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3. Science 289: 1159-1164.
24. Liu Y, Zhao Y, Zhang H, Liw E, Xu Q, (2005). The effects of overexpression of Nurr1 on vulnerability of SK-N-SH cells to neurotoxin 6-OHDA. Chin Pharmacological Bulletin 21 (10): 1171-1176.
25. Mayr B, Montminy M, (2001). Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol 2: 599-609.
26. McEvoy AN, Murphy EA, Ponnio T, Conneely OM, Bresnihan B, FitzGerald O, et al,. (2002). Activation of nuclear orphan receptor NURR1 transcription by NF-κB and cyclic adenosine 5'-monophosphate response element-binding protein in rheumatoid arthritis synovial tissue. J Immunol 168: 2979-2987.
27. Mix KS, Attur MG, Al-Mussawir H, Abramson SB, Brinckerhoff CE, Murphy EP, (2007). Transcriptional repression of matrix metalloproteinase gene expression by the orphan nuclear receptor NURR1 in cartilage. J Biol Chem 282: 9492-9504.
28. Moldovan SM, Nervina JM, Tetradis S, Camargo PM, (2009). Regulation of Nur77 gene expression by prostanoids in cementoblastic cells. Arch Oral Biol 54: 412-419.
29. Pan T, Xie W, Jankovic J, Le W, (2005). Biological effects of pramipexole on dopaminergic neuron-associated genes: relevance to neuroprotection. Neurosci Lett 377: 106-109.
30. Pearen M, Muscat GEO, (2010). Minireview: nuclear hormone receptor 4A signaling: implications for metabolic disease. Mol Endocrinol 24: 1891-1903.
31. Perona R, Montaner S, Saniger L, Sanchez-Perez I, Bravo R, Lacal JC, (1997). Activation of the nuclear factor-κB by Rho, CDC42, and Rac-1 proteins. Genes Dev 11: 463-475.
32. Regan JW, (2003). EP2 and EP4 prostanoid receptor signaling. Life Sci 74: 143-153.
33. Saijo K, Winner B, Carson CT, Collier JG, Boyer L, Rosenfeld MG, et al,. (2009). A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death. Cell 137: 47-59.
34. 2 targets squamous cell carcinoma cell with the activated epidermal growth factor receptor family for survival against 5-fluorouracil through NR4A2 induction. Cancer Lett 307: 227-236.
35. Steinberg RA, Cauthron RD, Symcox MM, Shuntoh H, (1993). Autoactivation of catalytic (C alpha) subunit of cyclic AMP-dependent protein kinase by phosphorylation of threonine 197. Mol Cell Biol 13: 2332-2341.
36. Sugimoto Y, Narumiya S, (2007). Prostaglandin E receptors. J Biol Chem 282: 11613-11617.
37. Thompson J, Winoto A, (2008). During negative selection, Nur77 family proteins translocate to mitochondria where they associate with Bcl-2 and expose its proapoptotic BH3 domain. J Exp Med 205: 1029-1036.
38. Vallabhapurapu S, Karin M, (2009). Regulation and function of NF-κB transcription factors in the immune system. Annu Rev Immunol 27: 693-733.
39. Vinukonda G, Csiszar A, Hu F, Dummula K, Pandey NK, Zia MT, et al,. (2010). Neuroprotection in a rabbit model of intraventricular haemorrhage by cyclooxygenase-2, prostanoid receptor-1 or tumour necrosis factor-alpha inhibition. Brain 133: 2264-2280.
40. Volakakis N, Kadkhodaei B, Joodmardi E, Wallis K, Panman L, Silvaggi J, et al,. (2010). NR4A orphan nuclear receptors as mediators of CREB-dependent neuroprotection. Proc Natl Acad Sci U S A 107: 12317-12322.
41. Zetterstrom RH, Solomin L, Jansson L, Hoffer BJ, Olson L, Perlmann T, (1997). Dopamine neuron agenesis in Nurr1-deficient mice. Science 276: 248-250.
42. Zhang T, Wang P, Ren H, Fan J, Wang G, (2009). NGFI-B nuclear receptor Nurr1 interacts with p53 and suppresses its transcriptional activity. Mol Cancer Res 7: 1408-1415.
43. Zhao Y, Bruemmer D, (2010). NR4A orphan nuclear receptors transcriptional regulators of gene expression in metabolism and vascular biology. Arterioscler Thromb Vasc Biol 30: 1535-1541.
44. Zhong H, SuYang H, Erdjument-Bromage H, Tempst P, Ghosh S, (1997). The transcriptional activity of NF-κB is regulated by the IκB-associated PKAc subunit through a cyclic AMP-independent mechanism. Cell 89: 413-424.